<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 41-year-old woman with metastatic <z:hpo ids='HP_0002861'>melanoma</z:hpo> was admitted to the hospital because of syncopal episodes, which had developed after the administration of an experimental chemotherapy agent that targeted Notch signaling, as part of a phase I clinical trial </plain></SENT>
<SENT sid="1" pm="."><plain>Cardiac monitoring revealed recurrent episodes of polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> correlating with the patient's <z:hpo ids='HP_0001279'>syncope</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Investigations into the cause of the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> led to the discovery of metastatic lesions within the left ventricular myocardium </plain></SENT>
<SENT sid="3" pm="."><plain>In presenting this case of polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> as the antemortem clinical manifestation of metastatic <z:hpo ids='HP_0002861'>melanoma</z:hpo> involving the heart, we discuss the importance of recognizing that cardiac <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> can manifest themselves as <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in patients with <z:hpo ids='HP_0002861'>malignant melanoma</z:hpo> who are undergoing active anticancer treatment </plain></SENT>
</text></document>